Kristie Blum


Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 10


Complete Response to Induction Therapy in Patients With Myc-Positive and Double-Hit Non-Hodgkin Lymphoma Is Associated With Prolonged Progression-Free Survival

by Jonathon B Cohen; Susan M. Geyer; Gerard Lozanski; Weiqiang Zhao; Nyla A. Heerema; Nathan C. Hall; Veena A. Nagar; Jessica A. Hemminger; Jeffrey A. Jones; Pierluigi Porcu; Beth A. Christian; Robert A. Baiocchi; Kami J. Maddocks; Joseph M. Flynn; Steven M. Devine; Kristie Blum



A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma

by Jonathon Cohen; Kami J. Maddocks; Ying Huang; Beth A. Christian; Samantha M. Jaglowski; Christopher Flowers; Kristie Blum



Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma

by Oscar Calzada; Jeffrey Switchenko; Joseph J Maly; Kristie Blum; Natalie Grover; Stephanie Mathews; Steven I Park; Max Gordon; Christopher Flowers; Jonathon Cohen



Complex Karyotype in Patients With Mantle Cell Lymphoma Predicts Inferior Survival and Poor Response to Intensive Induction Therapy

by I Brian Greenwell; Ashley D Staton; Michael J Lee; Jeffrey M. Switchenko; Debra Saxe; Joseph J Maly; Kristie Blum; Natalie S Grover; Stephanie Mathews; Max J Gordon; Alexey V Danilov; Narendranath Epperla; Timothy S Fenske; Mehdi Hamadani; Steven I Park; Christopher Flowers; Jonathon B Cohen



Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

by Gilles Salles; Stephen J. Schuster; Sven de Vos; Nina D. Wagner-Johnston; Andreas Viardot; Kristie Blum; Christopher Flowers; Wojciech J. Jurczak; Ian W. Flinn; Brad S. Kahl; Peter Martin; Yeonhee Kim; Sanatan Shreay; MAtthias Will; Bess Sorensen; Madlaina Breuleux; Pier Luigi Zinzani; Ajay K. Gopal



The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials

by Frederick Lansigan; Ian Barak; Brandelyn Pitcher; Sin-Ho Jung; Bruce D. Cheson; Myron Czuczman; Peter Martin; Eric Hsi; Heiko Schoder; Scott Smith; Nancy L. Bartlett; John P. Leonard; Kristie Blum



Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R

by Lisa Giulino-Roth; Tara O'Donohue; Zhengming Chen; Nancy L. Bartlett; Ann LaCasce; William Martin-Doyle; Matthew J. Barth; Kimberly Davies; Kristie Blum; Beth Christian; Carla Casulo; Sonali M. Smith; James Godfrey; Amanda Termuhlen; Matthew J. Oberley; Sarah Alexander; Sheila Weitzman; Burton Appel; Benjamin Mizukawa; Melinda Pauly